Navigation Links
Virology researcher awarded nearly $2 million to study chronic hepatitis E

For individuals with compromised immune systems, chronic infections can be deadly. Thanks to a nearly $2 million grant, a professor in the Virginia-Maryland Regional College of Veterinary Medicine will be working to better understand chronic hepatitis E virus infections.

X.J. Meng, a professor of virology on the college's Virginia Tech campus, received the five-year grant from the National Institutes of Health. He directs a lab in the Center for Molecular Medicine and Infectious Disease that is considered one of the world's leading hepatitis E virus research centers.

Meng and his colleagues have spent years studying the hepatitis E virus and are now turning their attention to chronic cases of the virus which causes more than 20 million liver infections every year.

"Hepatitis E is generally considered an acute, self-limiting disease," said Meng, who is in the department of biomedical sciences and pathobiology. "Patients with hepatitis E virus typically recover from the acute infection without going into chronicity, but in the last few years, there's been a significant increase in the number of chronic infections among immunocompromised individuals, such as organ transplant recipients, HIV/AIDS patients, and leukemia and lymphoma patients."

More than 60 percent of all hepatitis E infections and 65 percent of all hepatitis E deaths occur in East and South Asia, according to the World Health Organization. The project seeks to develop a chronic hepatitis E model to study how and why the disease progresses into chronicity and its possible medical prevention and treatment.

Meng and his colleagues hypothesize that the impairment of certain host-immune responses is responsible for the progression of acute hepatitis E virus infection into a chronic infection in individuals with compromised immune systems. The co-investigators of this project include Tanya LeRoith, an assistant professor of anatomic pathology; F. William Pierson, director of the Veterinary Teaching Hospital; and Lijuan Yuan, an assistant professor of virology and immunology, all faculty at the veterinary college.

Although hepatitis E is more common in developing countries, cases have been reported in the United States and other industrialized countries. The mortality rate associated with hepatitis E virus infection in humans is usually less than 1 percent, but that number can reach as high as 28 percent in pregnant women who have been infected.

"Interestingly, nearly all of the chronic cases were caused by a genotype of hepatitis E virus known to be zoonotic," Meng said.

In addition to humans, the zoonotic genotype of the virus has also been identified in pig, deer, rat, and rabbit. Meng and his colleagues are responsible for the discovery of swine hepatitis E virus in pigs, and avian hepatitis E virus in chickens.

Although the virus can be spread through contact with some animals or through contaminated water or food, it does not efficiently transfer from person to person.

Symptoms may include jaundice, fever, abdominal pain, nausea, and loss of appetite. The virus has a long incubation period, and those infected may not show symptoms until two weeks to two months after exposure.

What's more, Meng stressed the importance of food safety in preventing hepatitis E virus infections. In 2007, his research team found that 11 percent of pig livers sold in a grocery store in Blacksburg, Va., had hepatitis E virus contamination in them that could infect humans if served raw or undercooked.

Sporadic and cluster cases of hepatitis E virus infection involving a variety of sausage in southern France confirms that cooking pork medium to rare does not kill the virus and could lead to foodborne infection.

Meng's hepatitis E virus research program has been funded by NIH since 2000. This particular research project has successfully competed for renewal three times now. Meng's lab studies the molecular mechanisms of viral replication and pathogenesis and develops vaccines against emerging, reemerging, and zoonotic viral diseases.

It invented the first U.S. Department of Agriculture fully licensed commercial vaccine against the porcine circovirus type 2, which is currently being marketed worldwide.


Contact: Sherrie R. Whaley
Virginia Tech

Related biology news :

1. Researchers in Manchester find genetic key to preventing spine tumors
2. When It Comes To Genetic Code, Researchers Prove Optimum Isnt Always Best
3. UTSW researchers identify new enzyme that acts as innate immunity sensor
4. Leading RSV researcher publishes work at Le Bonheur Childrens
5. Researchers make racehorses fertile
6. Cities can reduce greenhouse gas emissions by 70 percent, says U of T researcher
7. USC researchers find possible genetic clues to organ development, birth defects
8. Researchers discover Achilles heel for lymphoid leukemia
9. Researchers find Asian needle ants displacing other aggressive invaders
10. Stanford researcher sheds new light on the mysteries of spider silk
11. Spanish researchers design biomarkers for the detection of dengue and West Nile virus
Post Your Comments:
Related Image:
Virology researcher awarded nearly $2 million to study chronic hepatitis E
(Date:11/19/2015)... VIEW, Calif. , Nov. 19, 2015  Based ... market, Frost & Sullivan recognizes BIO-key with the 2015 ... Leadership. Each year, Frost & Sullivan presents this award ... product line catering to the needs of the market ... the product line meets and expands on customer base ...
(Date:11/18/2015)... , November 18, 2015 ... published a new market report titled  Gesture Recognition Market ... Forecast, 2015 - 2021. According to the report, the global gesture ... is anticipated to reach US$29.1 bn by 2021, at ... North America dominated the global ...
(Date:11/17/2015)... , Nov. 17, 2015  Vigilant Solutions announces today ... its Board of Directors. --> ... recently retiring from the partnership at TPG Capital, one ... with over $140 Billion in revenue.  He founded and ... all the TPG companies, from 1997 to 2013.  In ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... 2015 Capricor Therapeutics, Inc. (NASDAQ: ... discovery, development and commercialization of first-in-class therapeutics, today announced ... is scheduled to present at the 2015 Piper Jaffray ... EST, at The Lotte New York Palace Hotel in ... . --> . ...
(Date:11/24/2015)... Nov. 24, 2015  PDL BioPharma, Inc. (PDL) (NASDAQ: ... the company,s president and chief executive officer, will present at ... week in New York City . The ... December 1, 2015 at 9:30 a.m. EST. ... the website at least 15 minutes prior to the presentation ...
(Date:11/24/2015)... ... November 24, 2015 , ... Whitehouse Laboratories is pleased to announce that ... facility will be strictly dedicated to basic USP 61, USP 62 and USP 51 ... to have complete chemistry and micro testing performed by one supplier. Management ...
(Date:11/23/2015)... with a certain type of lung nodule visible on lung ... cancer than men with similar nodules, according to a new ... the Radiological Society of North America ... Lung nodules are small masses of tissue in the lungs ... appearance on CT. Solid nodules are dense, and they obscure ...
Breaking Biology Technology: